echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: The wind is rising for Grilo

    Stroke: The wind is rising for Grilo

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Stroke is an important cause of global morbidity and mortality
    .


    Platelet aggregation is involved in the pathogenesis of stroke; antiplatelet therapy interferes with the development of these events and plays an important preventive role


    Compared with clopidogrel, the new generation of P2Y12 receptor inhibitors are more effective platelet inhibitors
    .


    Clopidogrel and prasugrel have the same active metabolites, but the latter has more effective biological activity, while ticagrelor, a direct-acting reversible P2Y12 receptor antagonist, inhibits ADP-mediated P2Y12-dependent platelets Gather


    Some recent data indicate that ticagrelor has potential benefits for stroke prevention in high-risk groups
    .


    Recently, the THALES trial further validated the potential of ticagrelor and aspirin to prevent stroke


    Based on the results of previous studies, there is growing interest in comparing ticagrelor alone and dual antiplatelet therapy to prevent ischemic stroke or transient ischemic attack (TIA)
    .


    In September 2021, András Komócsi from Hungary and others announced their research results on Stroke.


    A total of 26 randomized clinical trials with 124495 patients were included in this NMA analysis
    .


    Compared with the control group, ticagrelor combined with aspirin significantly reduced the risk of ischemic stroke by 20% (RR, 0.


    In the end, the author believes that ticagrelor combined with aspirin may provide a more favorable outcome for secondary stroke prevention in patients with vascular risk factors; however, this benefit may be accompanied by an increased risk of bleeding (including intracranial hemorrhage)


    Original source:

    Original source:

    Alexandra Bálint, Dániel Tornyos, et al.


    Network Meta-Analysis of Ticagrelor for Stroke Prevention in Patients at High Risk for Cardiovascular or Cerebrovascular Events in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.